Degradable scaffold-mediated synergistic matrix formation by endogenous cells: an in vivo manufacturing strategy for off-the-shelf vascular grafts to address clinical shortages.
He Y., Mo Y., Shen X., Xu J., Liu S., Sun X.
Animal Study on Scar, published in J Nanobiotechnology (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- J Nanobiotechnology (2026)
- Country
- England
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41526962
- PMCID
- PMC12888625
- DOI
- 10.1186/s12951-025-03993-9
Abstract (original English)
Abstract Cardiovascular bypass surgery is an important treatment for severe atherosclerosis, but the scarcity of autologous blood vessels restricts its clinical application. Although tissue-engineered vascular grafts (TEVGs) have potential, the long cycle of traditional in vitro culture makes it difficult to achieve "off-the-shelf" supply. This study innovatively proposes a strategy of guiding the in vivo self-assembly of endogenous cells via degradable scaffolds to rapidly construct cardiovascular bypass grafts. After implanting electrospun PLCL nanofibrous elastomer scaffolds subcutaneously in SD rats, host fibroblasts, and abdominal adipose-derived stem cells were recruited in only two weeks. These cells synergistically secreted extracellular matrix, forming an endogenous cell-empowered tissue-engineered PLCL (TE-P) vascular graft. The graft has appropriate stress relaxation and creep properties, and can support the adhesion and migration of arterial endothelial cells. In the abdominal aorta replacement model, TE-P remained patent 90 days after transplantation, with the vessel wall having synchronous contraction function and elasticity, and the effect of tissue structure reconstruction was close to that of the "gold standard" autologous blood vessels. Transcriptome analysis showed that TE-P promotes vascular regeneration through the synergistic mechanisms of energy metabolis
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Clinical Applications of Autologous Fat Grafting in Pathological Hand Conditions.
Systematic Review with a reported sample of 7 on Osteoarthritis, Scar, published in J Hand Surg Asian Pac Vol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 7
J Hand Surg Asian Pac Vol - Level AMeta-analysisPubMed
Stem cell therapy in thin endometrium and Asherman's syndrome: a systematic review and meta-analysis.
Meta-analysis with a reported sample of 323 on Scar, published in Eur J Obstet Gynecol Reprod Biol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 323
Eur J Obstet Gynecol Reprod Biol - Level AMeta-analysisEurope PMC
Therapeutic value of mesenchymal stem cell-derived extracellular vesicles in hypertrophic and keloid scars: a systematic review and meta-analysis
Meta-analysis on Chronic Wound, Scar, published in Front Cell Dev Biol (2026) — summary generated from the PubMed abstract.
- 2026
Front Cell Dev Biol - Level AMeta-analysisPubMed
Efficacy and safety of autologous cell-based therapies for atrophic acne scar treatment: an updated systematic review and meta-analysis with in-depth methodological and clinical insights.
Meta-analysis with a reported sample of 500 on Chronic Wound, Scar, published in Front Cell Dev Biol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 500
Front Cell Dev Biol - Level ASystematic ReviewEurope PMC
Comparative Efficacy and Safety of Fractional CO<sub>2</sub> Laser and Gold Microneedling Radiofrequency for Atrophic Acne Scars: A Systematic Review
Systematic Review on Chronic Wound, Scar, published in Skin Res Technol (2026) — summary generated from the PubMed abstract.
- 2026
Skin Res Technol - Level AMeta-analysisPubMed
Role of exosome therapy in reconstructive surgery: a review.
Meta-analysis on Chronic Wound, Scar, Immune Modulation, published in Front Med (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
Front Med (Lausanne)1 citations